, which is an important traditional Chinese medicine used for the treatment of kidney deficiency and neurodegenerative diseases. ECH is also the main phenolic component in Echinacea angustifolia and Echinacea pallida roots (Perry et al., 2001) , which are widely used in Europe, North America, and Australia for their immunostimulating activities. As a natural polyphenolic compound, ECH showed various bioactivities, such as antioxidative (Li et al., 1992; Xiong et al., 1996; Hu and Kitts, 2000; Cervellati et al., 2002) , neuroprotective (Den et al., 2004; Koo et al., 2005; Chen et al., 2007; Geng et al., 2007) , nitric oxide radical-scavenging (Xiong et al., 2000) , and antihepatotoxic activities (Houghton and Hikino, 1989; Wu et al., 2007) .
Phenylethanoid glycosides (PEGs), as a type of polyphenolic compounds, are widely distributed in different plant families and possess various pharmacological effects, such as antioxidation, anti-inflammation, antianoxia, immunomodulation. Echinacoside (ECH; [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl) ethoxy]-5-hydroxy-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-oxan-2-yl]oxymethyl]-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoan-3-yl](E)-3-(3,4-dihydroxyphenyl)prop-2-enoate) is one of the representative and major PEGs in Herba Cistanches (Tu et al., 1997) , which is an important traditional Chinese medicine used for the treatment of kidney deficiency and neurodegenerative diseases. ECH is also the main phenolic component in Echinacea angustifolia and Echinacea pallida roots (Perry et al., 2001) , which are widely used in Europe, North America, and Australia for their immunostimulating activities. As a natural polyphenolic compound, ECH showed various bioactivities, such as antioxidative (Li et al., 1992; Xiong et al., 1996; Hu and Kitts, 2000; Cervellati et al., 2002) , neuroprotective (Den et al., 2004; Koo et al., 2005; Chen et al., 2007; Geng et al., 2007) , nitric oxide radical-scavenging (Xiong et al., 2000) , and antihepatotoxic activities (Houghton and Hikino, 1989; Wu et al., 2007) .
Although ECH exhibited diverse bioactivities in in vivo and in vitro assays, only a few reports dealing with the metabolism and disposition of ECH are available. In our previous study on the pharmacokinetics and bioavailability of ECH in rat, the distribution and elimination of ECH were extremely fast (t 1/2␣ , 12.4 min; t 1/2␤ , 41.0 min), clearance was 0.0001 mg/kg/min/(ng/ml) after i.v. administration (5 mg/kg), and the bioavailability of ECH was only 0.83% (Jia et al., 2006) . The very low bioavailability of ECH was consistent with the results of Matthias et al. (2004) , in which ECH permeated poorly through the Caco-2 monolayers. Moreover, our pharmacokinetic data suggested that ECH was mostly metabolized after dosing. Therefore, we hypothesized that, in addition to the parent compound, some metabolic products of ECH may show biological activities, thereby contributing to the pharmacological efficacy of ECH in vivo. It was necessary to make the metabolic pathway of ECH clear to provide insight into the mechanism(s) through which it exerts its beneficial physiological effects. As a follow-up study, we isolated and identified eight metabolites of ECH from rat bile.
give three fractions 91, 90, 96, 95, 96, 93, 96 , and 95%, respectively, based on HPLC analyses.
Results
Isolation and Structure Elucidation of the Eight Metabolites. HPLC chromatography of the bile samples from rats administrated ECH intravenously or orally revealed eight new large peaks, named M1 to M8 (Fig. 1B) . The retention time of the eight metabolites was longer than that of ECH, which was hardly detected. The retention time of ECH was approximately 9.7 min.
By the above-mentioned methods, eight metabolites were obtained: M1 (25 mg (Table 1) (Tables 1 and 2 ) data of M6 with those of ECH suggested that the structure of M6 is closely related to that of ECH, except for two additional methoxyl groups. The location of the two methoxyl groups at C-3 and C-4ЈЈЈЈ were inferred by the NOESY spectrum (Warashina et al., 1992) . In the NOESY spectrum, one methoxyl signal at ␦ 3.83 exhibited a NOE effect with H-2 (␦ 6.85), one of the aromatic protons in the aglycone moiety, and another methoxyl signal at ␦ 3.86 showed a NOE effect with H-5ЈЈЈЈ (␦ 6.92) in the ester moiety. On the basis of spectral evidence, mainly 2D-NMR (HMBC and HSQC), the structure of M6 was elucidated as (Tables 1 and 2 ). On the basis of spectral evidence, mainly 2D-NMR (HMBC and HSQC), the structure of M5, an isomer of M6, was elucidated as cistanoside B, which was isolated previously from Cistanche salsa as a natural product (Kobayashi et al., 1984 (Tables 1 and 2 ). By careful analysis of 2D-NMR (HMBC and HSQC) spectral data, the structure of M7, an isomer of M6, was deduced as 2-(3-hydroxy-4-methoxyphenyl)-ethyl
O-␣-L-rhamnopyranosyl-(133)-[␤-D-glucopyranosyl-(136)]-(4-O-E-feruloyl)-␤-D-glucopyranoside, which was obtained previously
from Verbascum thapsus as a natural product (Warashina et al., 1992) .
Metabolite M8 was also obtained as an amorphous light yellowish powder. The positive ESI-MS showed a pseudomolecular ion peak at
Ϫ , which corresponds to the molecular formula C 37 H 50 O 20 by combining the 1 H and 13 C NMR data (Tables 1 and 2 ). By careful analysis of 2D-NMR (HMBC and HSQC) spectral data, the structure of M8, an isomer of M6, was deduced as 2-(3-hydroxy-4-
, which has been isolated from Verbascum sinaiticum as a natural product (Elgindi and Mabry, 2000 C NMR data of M1 with those of M6 suggested that they are identical except that M1 has an additional glucuronide group, which was further supported by M1 having 176 mass units more than M6. Meanwhile, the 13 C NMR data clearly showed the existence of a glucuronic acid [␦ 73 .1 (C-4ЈЈЈЈЈ), ␦ 74.7 (C-2ЈЈЈЈЈ), ␦ 76.5 (C-5ЈЈЈЈЈ), ␦ 77.3 (C-3ЈЈЈЈЈ), ␦ 102.9 (C-1ЈЈЈЈЈ), and ␦ 173.6 (C-6ЈЈЈЈЈ)]. In the HMBC spectrum, the anomeric proton of glucuronide (␦ 4.93, 1H, d, J ϭ 8.0 Hz) had correlation with C-3ЈЈЈЈ (␦ 147.9), which indicated that the linkage site of glucuronic acid moiety was at C-3ЈЈЈЈ. The ␤-form anomeric configuration of the glucuronic acid was judged from its coupling constant of the anomeric proton (J ϭ 8.0 Hz). Furthermore, the position of two methoxy groups at C-3 and C-4ЈЈЈЈ was confirmed by an NOE experiment in which the OCH 3 resonances at ␦ 3.79 and ␦ 3.83 were irradiated. The resulting NOE difference spectrum showed an enhancement of aromatic protons at ␦ 6.81 (H-2) and ␦ 6.98 (H-5ЈЈЈЈ), respectively. On the basis of spectral evidence, mainly 2D-NMR (HSQC, HMBC, and gCOSY), the structure of compound M1 was elucidated as 2-(3-methoxy- ). M2 was 176 mass units higher than that of M8, suggesting that it was a glucuronide conjugate of M8. Meanwhile, the 13 C NMR data clearly showed the existence of a glucuronic acid [␦ 73.0 (C-4ЈЈЈЈЈ), ␦ 74.6 (C-2ЈЈЈЈЈ), ␦ 76.5 (C-5ЈЈЈЈЈ), ␦ 77.3 (C-3ЈЈЈЈЈ), ␦ 102.9 (C-1ЈЈЈЈЈ), and ␦ 173.3 (C-6ЈЈЈЈЈ)]. In the HMBC spectrum, the anomeric proton of glucuronide (␦ 4.94, 1H, d, J ϭ 7.5 Hz) had correlation with C-3ЈЈЈЈ (␦ 147.9), which indicated that the linkage site of glucuronic acid moiety was at C-3ЈЈЈЈ. The ␤-form anomeric configuration of the glucuronic acid was judged from its coupling constant of the anomeric proton (J ϭ 7.5 Hz). Furthermore, the position of two methoxy groups at C-4 and C-4ЈЈЈЈ was confirmed by an NOE experiment in which the OCH 3 resonances at ␦ 3.75 and ␦ 3.83 were irradiated. The resulting NOE difference spectrum showed an enhancement of aromatic protons at ␦ 6.77 (H-5) and ␦ 6.98 (H-5ЈЈЈЈ), respectively. On the basis of spectral evidence, mainly 2D-NMR (HSQC, HMBC, and gCOSY), the structure of compound M2 was elucidated as 2-(3-hydroxy-4-methoxyphe- dmd.aspetjournals.org C NMR spectral data. The presence of a sulfate moiety was deduced by the appearance of intense distinctive absorption bands at 1268, 1045 cm Ϫ1 in the IR spectrum of M3, which was ascribed to the conjugated sulfuroxygen bond stretching vibration. The IR spectrum also showed absorption bands typical of hydroxyls (3428 cm ). The molecular formula of M3 was 80 mass units higher than that of M6, suggesting that M3 was a sulfate conjugate of M6. The 13 C NMR data of M3 were similar to those for M6, except for the downfield shifts of C-3 (ϩ4.3 ppm) and C-5 (ϩ7.5 ppm), and the upfield shifts of C-4 (Ϫ4.6 ppm), which showed that the sulfonate group was linked at C-4. On the basis of spectral evidence, mainly 2D-NMR (HSQC and HMBC), the structure of compound M3 was elucidated as 2-(3-methoxy-4-sulfophenyl)-ethyl
O-␣-L-rhamnopyranosyl-(133)-[␤-D-glucopyranosyl-(136)]-(4-O-Eisoferuloyl)-␤-D-glucopyranoside. Metabolite M4 was an amorphous light yellowish powder. Its HR-ESI-MS exhibited a pseudomolecular ion [M Ϫ H]
Ϫ at m/z 893.2348 (calc. for C 37 H 49 O 23 S; 893.2391). The molecular formula was determined to be C 37 H 50 O 23 S in combination with the 1 H and 13 C NMR spectral data. The presence of a sulfate moiety was deduced by the appearance of intense distinctive absorption bands at 1267, 1046 cm Ϫ1 in the IR spectrum of M4, which was ascribed to the conjugated sulfuroxygen bond stretching vibration. The IR spectrum also showed absorption bands typical of hydroxyls (3428 cm ). The molecular formula of M4 was 80 mass units higher than that of M8, suggesting that M4 was a sulfate conjugate of M8. The 13 C NMR data of M4 were similar to that of those of M8, except for the downfield shifts of C-2 (ϩ7.4 ppm) and C-4 (ϩ4.1 ppm), and the upfield shifts of C-3 (Ϫ4.7 ppm), which showed that the sulfonate group was linked at C-3. On the basis of spectral evidence, mainly 2D-NMR (HSQC and HMBC), the structure of compound M4 was elucidated as 2-(3-sulfo-4-methoxyphe-
nyl)-ethyl O-␣-L-rhamnopyranosyl-(133)-[␤-D-glucopyranosyl-(136)]-(4-O-E-isoferuloyl)-␤-D-glucopyranoside.

Discussion
During the drug metabolism studies, it becomes vitally important to identify and characterize the structure of metabolites. In recent years, new techniques were applied to identify and characterize the metabolites, such as gas chromatography-MS, LC-MS (Rüfer et al., 2006; Xu et al., 2006) , LC/NMR (Mutlib and Shockcor, 2003) , NMR (Zhang et al., 2004; Zeng et al., 2007) , and stable isotopes. In our study, three groups of positional isomers (M5, M6, M7, and M8; M1 and M2; and M3 and M4) were obtained. It was very difficult to identify the structure of these metabolites only by LC/multiple tandem mass spectrometry data. So, preparation of metabolites and further identification based on NMR data must be done. Of course, the direct isolation of the metabolites from bile, urine, or feces of humans or other animals was a tedious and laborious task, but it is the most reliable method in the identification of metabolites.
We have reported the low bioavailability (0.83%) of ECH in rat after oral administration (Jia et al., 2006 ). The extremely low bioavailability was mainly due to poor absorption of ECH through the gastrointestinal tract. In the present study, we have first investigated the metabolites of ECH from rat bile. Eight metabolites of ECH were isolated and identified by mass spectra, and IR and NMR spectroscopy, including 1 H NMR, 13 C NMR, nuclear Overhauser effect difference spectroscopy, and twodimensional NMR (HMQC, HMBC, gCOSY, and NOESY). All of the eight metabolites were phase II metabolites. Among them, M5 to M8 were O-dimethyl conjugates; M1 and M2 and M3 and M4 were O-dimethyl glucuronides and O-dimethyl sulfates, respectively.
Few reports about the metabolism of PEGs can be found. Our group reported previously that ECH was hydrolyzed to acteoside by enzymes of bacterial origin in the large intestine of beagle dogs (Lei et al., 2001) . In the present study, three types of metabolic pathways for ECH in rats were revealed (Fig. 2) . One pathway was the methylation of the phenolic hydroxyl groups in the ester and aglycone for ECH, and four positional isomeric O-dimethyl metabolites were formed. It is interesting to note that the monomethyl metabolites were not isolated and identified, suggesting that phenolic hydroxyls on ester or aglycon are easy to methylate and that the catechol is hard to methylate simultaneously. The second pathway was that the glucuronidation tends to occur on hydroxyl groups of the ester moiety in ECH. Two isomeric O-dimethyl glucuronides were formed. The third pathway was that the sulfation tends to occur on hydroxyl groups of the aglycone moiety in ECH. Two O-dimethyl sulfates were identified. In addition, the author also studied the metabolism of ECH in the gut and the serum in rat. Two metabolites were detected in the gut. And they were identified as acteoside and caffeic acid based on their retention times compared with authentic standards and on LC-MS (ESI-tandem mass spectrometry) analyses. It was reported previously that the preferential conjugation sites existed in the conjugate formation for flavonoid compounds (Morand et al., 1998; Boersma et al., 2002; Havsteen, 2002; Chen et al., 2006; Bursztyka et al., 2008) and caffeic acid and its oligomer condensate (Moridani et al., 2002; Zhang et al., 2004) . In the present study, the preferential conjugation sites also existed in the conjugate formation for ECH, which may be related to the steric configuration of the ECH or COMT, UDP-glucuronosyltransferase, and sulfotransferase (species difference). Of the three types of metabolites in rat, the major conjugates were the methyl ethers and the glucuronides, whereas the sulfates were minor. Among four methyl ethers, the content of M6 was larger than others by comparing their peak area in HPLC chromatogram, which revealed the possibilities of the methylation on 4ЈЈЈЈ-OH and 3-OH in ECH at the same time was larger than that of other hydroxyls. Furthermore, the glucuronidation with a high selectivity only occurred on the 3ЈЈЈЈ-OH group of the ester. So, the 3ЈЈЈЈ-OH group of the ester of ECH was determined as the preferential site for glucuronosyl conjugation compared with other three hydroxyl groups. Moreover, sulfate ester formation occurred at hydroxyl-3 or -4 of the aglycone, whereas the ester contained 3ЈЈЈЈ-OH and 4ЈЈЈЈ-OCH 3 . However, the conjugates with mixed methylates/sulfates/ glucuronides or sulfate/glucuronides were not found. Further studies should clarify whether they were formed or not.
Metabolism of ECH involves methylation by the enzyme COMT, glucuronidation by the enzyme UDP-glucuronosyltransferase, and sulfation by sulfotransferase in the liver. COMT is an intracellular enzyme, widely distributed throughout the organs of the body, with the highest COMT activity is in the liver, followed by the kidneys and gastrointestinal tract (Karhunen et al., 1994) . Some phenolic compounds, such as caffeic acid (Moridani et al., 2002) , quercetin (O'Leary et al., 2003) , and magnesium lithospermate B (Zhang et al., 2004) , were reported to be methylated in the catechol moiety by COMT. In the present study, ECH were methylated in the catechol moiety at the 3ЈЈЈЈ,4ЈЈЈЈ-OH of the ester and at the 3-,4-OH of the aglycone, to form four O-dimethylated conjugates (M5, M6, M7, and M8), respectively, by COMT. In addition, glucuronidation and sulfation reactions may well be a major cause for the lack of toxicity of phenolic compounds (Morand et al., 1998) and seemed to be the other major metabolic pathways to biotransform catechols into conjugates unable to enter a redox cycling reaction for phenolic compounds (Bursztyka et al., 2008) . Two O-dimethyl glucuronides and two Odimethyl sulfates were also identified in the present study. Moreover, the glucuronidation and sulfadation improve the water solubility of methoxylated derivatives of ECH and consequently favor their elimination. Metabolism needs to be investigated further, and the enzymes involved in the formation of metabolites of ECH need to be identified. In summary, eight phase II metabolites have been isolated and identified from bile collected from rats after oral or intravenous administration of ECH, and four of them were O-dimethyl conjugates, two were O-dimethyl glucuronides, and two were O-dimethyl sulfates. The methylation and glucuronidation conjugates were major metabolites, whereas sulfation conjugates were minor. The hydroxyl groups of the aglycone and the ester could also be methylated. The preferential site for the glucuronidation was 3ЈЈЈЈ-OH of the ester, and the preferential sites for sulfation were 3-or 4-OH of the aglycone. All above-mentioned results are important for the understanding of ECH metabolism in rats and provide information and reference for the further metabolic investigation of ECH in humans.
